Dimension Capital II, L.P. 3
3 · Odyssey Therapeutics, Inc. · Filed May 12, 2026
Insider Transaction Report
Form 3
Dimension Capital II, L.P.
Director
Holdings
- 512,862
Common Stock
[F1][F2] Series D Convertible Preferred Stock
[F3][F1][F2]→ Common Stock (1,709,543 underlying)
Footnotes (3)
- [F1]Held directly by Dimension Capital II, L.P. ("Dimension Capital II"). Dimension Management, L.P. ("Dimension Management") is the investment advisor to Dimension Capital II. Dimension Management GP, L.P. is the general partner of Dimension Management, and Dimension Management GP, LLC ("Dimension Management GP") is the general partner of Dimension Management GP, L.P. Dimension Capital II GP, LLC ("Dimension Capital II GP") is the general partner to the general partner of Dimension Capital II. Adam Goulburn, Zavain Dar, and Nan Li are members of each of Dimension Management GP and Dimension Capital II GP. Mr. Li serves on the Issuer's board of directors.
- [F2]Each of Dimension Management, Dimension Management GP, Dimension Capital II GP, Mr. Goulburn, Mr. Dar, and Mr. Li disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein.
- [F3]The Series D Preferred Stock is convertible into Common Stock on a 1-for-9.7170 basis at any time at the option of the holder. The Series D Preferred Stock will convert immediately prior to the closing of the Issuer's initial public offering into the number of shares shown in column 3 without payment of consideration.
Signature
/s/ Adam Goulburn - for Dimension Capital II, L.P., By: Dimension Capital II GP, LP, its general partner, By: Adam Goulburn, Member|2026-05-12